Nazli Dizman, MD, discussed the current measures for enforcing ASCO’s language of respect guidelines in the renal cell ...

Young people with cancer are at high risk for experiencing financial distress, according to a new study. Financial distress ...

A nurse practitioner discusses ASCO’s recommendations of CDK4/6 inhibitors—namely abemaciclib and ribociclib—in certain ...

Many people with cancer are interested in using cannabis for symptom management, but few talk to their doctor about it. ASCO ...

Cardiff Oncology (CRDF) announced the publication of data from its Phase 2 trial evaluating onvansertib in combination with Folfiri and ...

Companies claim that some screenings can identify dozens of cancers from a simple blood test. Here's what they can and can't ...

Research suggests that prior authorization has negative effects on patients with cancer and oncology providers.

This month, access to cancer care in southwest Montana has expanded, as the result of a pilot program developing a ...

Findings underscore that the combination of onvansertib with FOLFIRI and bevacizumab demonstrates clinical activity and is well tolerated in ...

International collaboration meets in Vietnam to facilitate treatment recommendation guidelines that help people with cancer to live better lives. NCCN Chief Executive Officer Crystal S. Denlinger, MD ...

STATEN ISLAND, N.Y. – Staten Island University Hospital (SIUH) has appointed Dr. Thomas Bradley director of hematology and ...

A resolution was unanimously passed at the inaugural Euro-American Forum on Cancer in Dublin to enhance transatlantic ...